ROS触发的半球粘合微电机用于炎症性肠病治疗
Xiaoya Ding1,2, Jiante Li3, Luoran Shang4
1MOE Innovation Center for Basic Research in Tumor Immunotherapy, Anhui Province Key Laboratory of Tumor Immune Microenvironment and Immunotherapy, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Advanced materials (Deerfield Beach, Fla.)
|December 30, 2025
概括
新型半球体粘合微电机 (HMP) 提供治疗炎症性肠病 (IBD) 的药物. 这些ROS响应的医疗保健医生通过减少炎症和恢复肠道屏障功能,对胃肠道疾病治疗充满希望.
科学领域:
- 生物医学工程 生物医学工程
- 材料科学 材料科学 材料科学
- 纳米技术纳米技术
背景情况:
- 炎症性肠病 (IBD) 治疗需要先进的药物输送系统.
- 目前的研究重点是微运动设计,以提高IBD治疗效果.
- 反应性氧物种 (ROS) 与IBD病原发生有关.
研究的目的:
- 开发新型ROS响应的半球体粘合微电机 (HMP) 以有效治疗IBD.
- 在IBD模型中研究甲 (DXM) 载荷的HMP的治疗疗效.
- 探索HMP介导的IBD治疗背后的机制.
主要方法:
- 使用微流体电子喷雾技术制造HMP.
- 用白金 (Pt) 涂覆HMP,用于ROS触发的推进和多巴胺 (DOPA) 用于组织粘附.
- 用德克萨米他 (DXM) 充满HMP,以获得抗炎作用.
主要成果:
- 医疗保健医生证明了ROS响应的推进和出色的组织粘附.
- 装有DXM的HMP显示出显著的抗氧化和抗炎能力.
- HMP治疗缓解了炎症反应,恢复了上皮屏障功能,并减轻了IBD症状.
结论:
- 医疗保健医生代表着在IBD治疗中提供向药物治疗的有希望的平台.
- 开发的微运动系统为治疗胃肠道疾病提供了一种新的策略.
- 医疗保健医生通过减少氧化应激和保护肠道屏障,有效治疗IBD.
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
439
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
439
Inflammatory Bowel Disease II: Crohn's Disease
912
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
912
Gastrointestinal Motility Disorders
1.0K
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
1.0K
Inflammatory Bowel Disease V: Surgical Management
423
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
423
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
454
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
454
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
851
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
851


